Extended Research Article
3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT
Timothy Iveson
,
Kathleen A Boyd
,
Rachel S Kerr
,
Jose Robles-Zurita
,
Mark P Saunders
,
Andrew H Briggs
et al.
-
Journal:
Health Technology Assessment Volume: 23, Issue: 64
-
Published:
18 December 2019